yohimbine has been researched along with Acute Confusional Senile Dementia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blitzer, RD; Cornfeldt, M; Davis, L; Effland, RC; Haroutunian, V; Huger, FP; Klein, JT; Landau, E; Martin, LL; Olsen, GE; Petko, WW; Smith, CP; Wilker, JC; Wong, GS | 1 |
| Cynis, H; Demuth, HU; Hartlage-Rübsamen, M; Jäger, C; Koch, B; Morawski, M; Rossner, S; Schilling, S; Schliebs, R; Waniek, A; Zeitschel, U | 1 |
| Dobie, DJ; Le Corre, P; Le Verge, R; Murray, S; Pascualy, M; Peskind, ER; Raskind, MA; Veith, RC; Wingerson, D | 1 |
| Aisen, PS; Bierer, LM; Davidson, M; Davis, KL; Ryan, TM; Schmeidler, J; Stern, RG | 1 |
| Chevanne, F; Le Corre, PA; Le Verge, R; Peskind, ER; Raskind, MA | 1 |
| Brodkin, K; Dobie, DJ; Elrod, R; Jensen, C; Murray, S; Pascualy, M; Peskind, ER; Petrie, E; Raskind, MA; Veith, RC | 1 |
| Goldstein, DS; Holmes, C; Peskind, ER; Raskind, MA | 1 |
| Allain, H; Bentué-Ferrer, D | 1 |
| Adunsky, A; Hershkowitz, M; Rabinowitz, M | 1 |
| Fujiwara, M; Kameyama, M; Shimohama, S; Taniguchi, T | 1 |
3 trial(s) available for yohimbine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.
Topics: Adult; Aged; Aging; Alzheimer Disease; Ambulatory Care; Analysis of Variance; Blood Pressure; Clonidine; Female; Heart Rate; Humans; Male; Norepinephrine; Psychiatric Status Rating Scales; Stimulation, Chemical; Yohimbine | 1995 |
A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer disease.
Topics: Administration, Oral; Aged; Alzheimer Disease; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Middle Aged; Neuropsychological Tests; Physostigmine; Pilot Projects; Yohimbine | 1993 |
Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Aging; Alzheimer Disease; Blood Pressure; Clonidine; Epinephrine; Female; Heart Rate; Humans; Male; Yohimbine | 1998 |
7 other study(ies) available for yohimbine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Biogenic Amines; Brain; In Vitro Techniques; Indoles; Magnetic Resonance Spectroscopy; Parasympatholytics; Pyridines; Rats; Structure-Activity Relationship | 1996 |
Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Aminoacyltransferases; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Autoradiography; Cells, Cultured; Dihydroalprenolol; Female; Green Fluorescent Proteins; Hippocampus; Humans; Male; Mice; Mice, Transgenic; Neurons; Potassium Chloride; Prazosin; Protein Binding; Pyrrolidonecarboxylic Acid; Receptors, Adrenergic; Time Factors; Tritium; Yohimbine | 2011 |
Cerebrospinal fluid and plasma disposition of yohimbine and 11-hydroxy-yohimbine in young and older healthy subjects, and Alzheimer's disease patients.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Aging; Alzheimer Disease; Female; Humans; Male; Middle Aged; Norepinephrine; Receptors, Adrenergic, alpha-2; Reference Values; Yohimbine | 1997 |
Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Aging; Alzheimer Disease; Antimetabolites; Catechols; Chromatography, High Pressure Liquid; Clonidine; Cognition Disorders; Dihydroxyphenylalanine; Extracellular Space; Female; Humans; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Neurons; Neuropsychological Tests; Norepinephrine; Yohimbine | 1999 |
[Effect of almitrine/raubasine on cerebral metabolism in the elderly].
Topics: Aged; Almitrine; Alzheimer Disease; Animals; Brain; Brain Ischemia; Energy Metabolism; Humans; Neurons; Nootropic Agents; Oxygen Consumption; Secologanin Tryptamine Alkaloids; Yohimbine | 2002 |
Alzheimer's dementia and binding to alpha 2 adrenoreceptors in platelets.
Topics: Aged; Alzheimer Disease; Biomarkers; Blood Platelets; Female; Humans; Male; Receptors, Adrenergic, alpha; Sex Factors; Yohimbine | 1989 |
Biochemical characterization of alpha-adrenergic receptors in human brain and changes in Alzheimer-type dementia.
Topics: Aged; Alzheimer Disease; Binding, Competitive; Brain; Cell Membrane; Cerebellum; Female; Hippocampus; Humans; Kinetics; Male; Prazosin; Receptors, Adrenergic, alpha; Substantia Innominata; Tissue Distribution; Yohimbine | 1986 |